TY - JOUR
T1 - Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design
AU - Molebatsi, Kesaobaka
AU - Gabaitiri, Lesego
AU - Mokgatlhe, Lucky
AU - Moyo, Sikhulile
AU - Gaseitsiwe, Simani
AU - Wirth, Kathleen E.
AU - DeGruttola, Victor
AU - Tchetgen Tchetgen, Eric
N1 - Funding Information:
Eric Tchetgen Tchegen also received a grant from National Cancer Institute (NCI) R01CA222147.
Funding Information:
information National Cancer Institute, R01CA222147; National Institute of Health, R01AI27271; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), DEL-15-006; U.S. President's Emergency Plan for AIDS Relief, GH0001911; U01 GH000447; Wellcome Trust, 107752/Z/15/ZThis work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant # DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The BCPP study was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement U01 GH000447 and GH0001911. Eric Tchetgen Tchegen and Kathleen E. Wirth received support from the National Institute of Health (NIH) R01AI27271. Eric Tchetgen Tchegen also received a grant from National Cancer Institute (NCI) R01CA222147.
Funding Information:
This work was supported through the Sub‐Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant DEL‐15‐006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant 107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. # #
Funding Information:
Eric Tchetgen Tchegen and Kathleen E. Wirth received support from the National Institute of Health (NIH) R01AI27271.
Funding Information:
The BCPP study was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of cooperative agreement U01 GH000447 and GH0001911.
Publisher Copyright:
© 2020 John Wiley & Sons, Ltd.
PY - 2020/10/30
Y1 - 2020/10/30
N2 - Development of methods to accurately estimate human immunodeficiency virus (HIV) incidence rate remains a challenge. Ideally, one would follow a random sample of HIV-negative individuals under a longitudinal study design and identify incident cases as they arise. Such designs can be prohibitively resource intensive and therefore alternative designs may be preferable. We propose such a simple, less resource-intensive study design and develop a weighted log likelihood approach which simultaneously accounts for selection bias and outcome misclassification error. The design is based on a cross-sectional survey which queries individuals' time since last HIV-negative test, validates their test results with formal documentation whenever possible, and tests all persons who do not have documentation of being HIV-positive. To gain efficiency, we update the weighted log likelihood function with potentially misclassified self-reports from individuals who could not produce documentation of a prior HIV-negative test and investigate large sample properties of validated sub-sample only versus pooled sample estimators through extensive Monte Carlo simulations. We illustrate our method by estimating incidence rate for individuals who tested HIV-negative within 1.5 and 5 years prior to Botswana Combination Prevention Project enrolment. This article establishes that accurate estimates of HIV incidence rate can be obtained from individuals' history of testing in a cross-sectional cohort study design by appropriately accounting for selection bias and misclassification error. Moreover, this approach is notably less resource-intensive compared to longitudinal and laboratory-based methods.
AB - Development of methods to accurately estimate human immunodeficiency virus (HIV) incidence rate remains a challenge. Ideally, one would follow a random sample of HIV-negative individuals under a longitudinal study design and identify incident cases as they arise. Such designs can be prohibitively resource intensive and therefore alternative designs may be preferable. We propose such a simple, less resource-intensive study design and develop a weighted log likelihood approach which simultaneously accounts for selection bias and outcome misclassification error. The design is based on a cross-sectional survey which queries individuals' time since last HIV-negative test, validates their test results with formal documentation whenever possible, and tests all persons who do not have documentation of being HIV-positive. To gain efficiency, we update the weighted log likelihood function with potentially misclassified self-reports from individuals who could not produce documentation of a prior HIV-negative test and investigate large sample properties of validated sub-sample only versus pooled sample estimators through extensive Monte Carlo simulations. We illustrate our method by estimating incidence rate for individuals who tested HIV-negative within 1.5 and 5 years prior to Botswana Combination Prevention Project enrolment. This article establishes that accurate estimates of HIV incidence rate can be obtained from individuals' history of testing in a cross-sectional cohort study design by appropriately accounting for selection bias and misclassification error. Moreover, this approach is notably less resource-intensive compared to longitudinal and laboratory-based methods.
UR - http://www.scopus.com/inward/record.url?scp=85090063602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090063602&partnerID=8YFLogxK
U2 - 10.1002/sim.8661
DO - 10.1002/sim.8661
M3 - Article
C2 - 32875624
AN - SCOPUS:85090063602
SN - 0277-6715
VL - 39
SP - 3255
EP - 3271
JO - Statistics in Medicine
JF - Statistics in Medicine
IS - 24
ER -